Douglas W. Losordo

Douglas Losordo, MD, currently serves as Chief Medical Officer at Cadrenal Therapeutics, Inc. and as an Independent Director at Longeveron LLC. With extensive experience in leadership roles, Losordo held positions such as Global Head Clinical Research, Development and Operations at American Regent, Inc., and Chief Medical Officer at both KBP Biosciences and Caladrius Biosciences, where significant restructuring of R&D processes was achieved. Academic contributions include serving as Clinical Professor of Medicine at NYU Langone Medical Center and as Professor of Medicine at Northwestern University. Educational qualifications include an M.D. from The Robert Larner, M.D. College of Medicine at The University of Vermont and a business degree from Northwestern University's Kellogg School of Management.